UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metformin doses to ensure efficacy and safety in patients with reduced kidney function

PloS one, 2021-02, Vol.16 (2), p.e0246247

2021

Volltextzugriff (PDF)

A Bayesian Dose-Individualization Method for Warfarin

Clinical pharmacokinetics, 2013-01, Vol.52 (1), p.59-68

2013

Volltextzugriff (PDF)

Understanding the time course of pharmacological effect: a PKPD approach

British journal of clinical pharmacology, 2011-06, Vol.71 (6), p.815-823

2011

Volltextzugriff (PDF)

Development of a Bayesian Forecasting Method for Warfarin Dose Individualisation

Pharmaceutical research, 2011-05, Vol.28 (5), p.1100-1111

2011

Volltextzugriff (PDF)

The population pharmacokinetics of allopurinol and oxypurinol in patients with gout

European journal of clinical pharmacology, 2013-07, Vol.69 (7), p.1411-1421

2013

Volltextzugriff (PDF)

Interpreting population pharmacokinetic‐pharmacodynamic analyses – a clinical viewpoint

British journal of clinical pharmacology, 2011-06, Vol.71 (6), p.807-814

2011

Volltextzugriff (PDF)

Easing the way to achieving target serum urate in people with gout: protocol for a non-inferiority randomised strategy trial using an allopurinol dosing model in Aotearoa/New Zealand (the Easy-Allo Study)

BMJ open, 2024-08, Vol.14 (8), p.e084665

2024

Volltextzugriff (PDF)

The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)

European journal of clinical pharmacology, 2020-02, Vol.76 (2), p.239-247

2020

Volltextzugriff (PDF)

The influence of flip‐flop in population pharmacokinetic analyses

CPT: pharmacometrics and systems pharmacology, 2023-03, Vol.12 (3), p.285-287

2023

Volltextzugriff (PDF)

The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics

Clinical and translational science, 2023-03, Vol.16 (3), p.422-428

2023

Volltextzugriff (PDF)

Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study

ACR open rheumatology, 2024-07, Vol.6 (7), p.403-411

2024

Volltextzugriff (PDF)

Impaired response or insufficient dosage?—Examining the potential causes of “inadequate response” to allopurinol in the treatment of gout

Seminars in arthritis and rheumatism, 2014-10, Vol.44 (2), p.170-174

2014

Volltextzugriff (PDF)

Deterministic identifiability of population pharmacokinetic and pharmacokinetic–pharmacodynamic models

Journal of pharmacokinetics and pharmacodynamics, 2017-10, Vol.44 (5), p.415-423

2017

Volltextzugriff (PDF)

Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy

Annual review of pharmacology and toxicology, 2021-01, Vol.61 (1), p.225-245

2021

Volltextzugriff (PDF)

The Influence of Dosing Time, Variable Compliance and Circadian Low‐Density Lipoprotein Production on the Effect of Simvastatin: Simulations from a Pharmacokinetic–Pharmacodynamic Model

Basic & clinical pharmacology & toxicology, 2011-12, Vol.109 (6), p.494-498

2011

Volltextzugriff (PDF)

Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate‐Lowering Response—In Search of a Minimum Effective Oxypurinol Concentration

Clinical and translational science, 2020-01, Vol.13 (1), p.110-115

2020

Volltextzugriff (PDF)

Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool

Therapeutic drug monitoring, 2016-12, Vol.38 (6), p.677-683

2016

Volltextzugriff (PDF)

Nonmedical use of prescription drugs

British journal of clinical pharmacology, 2021-04, Vol.87 (4), p.1635-1636

2021

Volltextzugriff (PDF)

Measuring the Development of Therapeutic-Decision-Making Skills by Practicing Pharmacists Undertaking a University-Based Postgraduate Clinical Qualification at Distance

Pharmacy, 2020-05, Vol.8 (2), p.83

2020

Volltextzugriff (PDF)

Perspectives on the past, present, and future of pharmacometrics

British journal of clinical pharmacology, 2022-02, Vol.88 (4), p.1403-1405

2022

Volltextzugriff (PDF)

Medication adherence research comes of age

British journal of clinical pharmacology, 2023-07, Vol.89 (7), p.1914-1917

2023

Volltextzugriff (PDF)

Evaluation of designs for renal drug studies based on the European Medicines Agency and Food and Drug Administration guidelines for drugs that are predominantly secreted

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.1401-1410

2021

Volltextzugriff (PDF)

Leverage points for establishing clinical decision-maker as a vital component of pharmacists’ professional identity

Research in social and administrative pharmacy, 2024-09, Vol.20 (9), p.954-957

2024

Volltextzugriff (PDF)

Estimation of adherence to urate‐lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient‐reported dosing

British journal of clinical pharmacology, 2024-05, Vol.90 (5), p.1322-1332

2024

Volltextzugriff (PDF)

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID‐19 (SARS‐COV‐2) treatments

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.707-711

2021

Volltextzugriff (PDF)

1 – 25 von 428

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(401)
Mit Volltextzugriff
(363)

Publikationsform

Sprache

Englisch
(425)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(322)
Life Sciences & Biomedicine
(256)
Humans
(198)
Male
(121)
Female
(115)
Middle Aged
(77)
Adult
(74)
Aged
(66)
Biological And Medical Sciences
(66)
Medical Sciences
(57)
Pharmacology & Pharmacy
(56)
General & Internal Medicine
(36)
Physical Sciences
(35)
Science & Technology - Other Topics
(32)
Medicine, General & Internal
(31)
Multidisciplinary Sciences
(29)
Adolescent
(28)
Child
(27)
Animals
(25)
Treatment Outcome
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Metformin doses to ensure efficacy and safety in patients with reduced kidney function

A Bayesian Dose-Individualization Method for Warfarin

Understanding the time course of pharmacological effect: a PKPD approach

Development of a Bayesian Forecasting Method for Warfarin Dose Individualisation

The population pharmacokinetics of allopurinol and oxypurinol in patients with gout

Interpreting population pharmacokinetic‐pharmacodynamic analyses – a clinical viewpoint

Easing the way to achieving target serum urate in people with gout: protocol for a non-inferiority randomised strategy trial using an allopurinol dosing model in Aotearoa/New Zealand (the Easy-Allo Study)

The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)

The influence of flip‐flop in population pharmacokinetic analyses

The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics

Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study

Impaired response or insufficient dosage?—Examining the potential causes of “inadequate response” to allopurinol in the treatment of gout

Deterministic identifiability of population pharmacokinetic and pharmacokinetic–pharmacodynamic models

Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy

The Influence of Dosing Time, Variable Compliance and Circadian Low‐Density Lipoprotein Production on the Effect of Simvastatin: Simulations from a Pharmacokinetic–Pharmacodynamic Model

Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate‐Lowering Response—In Search of a Minimum Effective Oxypurinol Concentration

Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool

Nonmedical use of prescription drugs

Measuring the Development of Therapeutic-Decision-Making Skills by Practicing Pharmacists Undertaking a University-Based Postgraduate Clinical Qualification at Distance

Perspectives on the past, present, and future of pharmacometrics

Medication adherence research comes of age

Evaluation of designs for renal drug studies based on the European Medicines Agency and Food and Drug Administration guidelines for drugs that are predominantly secreted

Leverage points for establishing clinical decision-maker as a vital component of pharmacists’ professional identity

Estimation of adherence to urate‐lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient‐reported dosing

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID‐19 (SARS‐COV‐2) treatments

Suchergebnisse filtern